Eliza C Spears, FNP-BC in New London, CT - Nurse Practitioner

Eliza C Spears, FNP-BC is a Nurse Practitioner - Family based in New London, Connecticut. Eliza C Spears is licensed to practice in Connecticut (license number 12869) and her current practice location is 254 Hempstead St, New London, Connecticut. She can be reached at her office (for appointments etc.) via phone at (860) 437-4550.

NPI number for Eliza C Spears is 1023587995 and her current mailing address is 15 River Meadow Dr, Hope Valley, Rhode Island. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1023587995.

Contact Information

	Eliza C Spears, FNP-BC
	254 Hempstead St, New London, CT 06320-6224
	(860) 437-4550
	Not Available

Provider's Profile

Full Name	Eliza C Spears
Gender	Female
Speciality	Nurse Practitioner - Family
Location	254 Hempstead St, New London, Connecticut
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1023587995
Provider Enumeration Date: 11/20/2018
Last Update Date: 02/12/2024

Medical Identifiers

Medical identifiers for Eliza C Spears such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1023587995	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363LF0000X	Nurse Practitioner - Family	12869 (Connecticut)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Eliza C Spears is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Eliza C Spears, FNP-BC 15 River Meadow Dr, Hope Valley, RI 02832-1410 Ph: (401) 623-9557	Eliza C Spears, FNP-BC 254 Hempstead St, New London, CT 06320-6224 Ph: (860) 437-4550

News Archive

Specific protein can be used as a brain marker to indicate whether emotional memories can be changed

Researchers have discovered that a particular protein can be used as a brain marker to indicate whether emotional memories can be changed or forgotten.

Diabetech and Cinterion Wireless Modules announce their collaboration on fourth generation GlucoMON platform

Cinterion Wireless Modules, the global leader in cellular machine-to-machine (M2M) communication modules, and Diabetech, the leader in patient-centric health care programs, today announced their collaboration on the fourth generation GlucoMON® platform, the world's easiest-to-use wireless diabetes management system designed to help the over 220 million people worldwide struggling to manage the global diabetes and pre-diabetes pandemic.

Study on mitochondria function

For such crucial biological actors, much remains unknown about exactly how mitochondria function. A new study, published Aug. 12 in the online journal PLoS One, sheds light on mitochondrial biology. Using genetic engineering, researchers interrupted the activity of individual genes directly involved in the production of energy within mitochondria. "If we knock down the function of specific system components, what happens?" said study leader Marni J. Falk, M.D., who directs the Mitochondrial-Genetics Disease Clinic at The Children's Hospital of Philadelphia. "Our ultimate goal is to translate the knowledge into targeted therapies, that is, effective ways to intervene. But first we need to understand the underlying disease mechanisms."

Exposure to harmful quantities of lead may lead to juvenile delinquency

Lead is a common element but is found in old paints (including those once used on children's toys), soil, old piping, water, and the atmosphere from lead-containing vehicular fuels, even drinking vessels. At high dose it is lethal but also causes seemingly trivial symptoms such as headaches. However, in children lead can also lead to irreversible damage to the organs, the kidneys in particular, and the nervous system including the brain.

Data from FAME Phase 3 study for Iluvien presented at Angiogenesis 2010

pSivida Corp., a leader in the development of ophthalmic sustained release drug delivery products, with two of the only three such products approved by the FDA for treatment of back of the eye diseases, today said that 24-month data from the FAME Phase 3 study for Iluvien presented at Angiogenesis 2010 included additional efficacy and safety data that reinforced the positive top-line results reported in December 2009 by pSivida and its licensee, Alimera Sciences, Inc.

Nurse Practitioner Nurses in New London, CT

Mr. Stephen Daniel Socha, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-442-0711
Mrs. Susan H. Austen, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 15 Mohegan Ave,, New London, CT 06320 Phone: 860-437-3611 Fax: 860-437-1801
Melissa Milvenan, RN, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Shaws Cv, New London, CT 06320 Phone: 860-447-8304
Emily Antonia Johnson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 234a Bank St, New London, CT 06320 Phone: 860-442-0290
Ms. Eileen Joy Odonnell, RN, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 345 Montauk Ave, New London, CT 06320 Phone: 860-444-6711 Fax: 860-437-0650
Katherine Joanne Luther, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-442-0711 Fax: 860-444-5114

Eliza C Spears, FNP-BC - Nurse Practitioner in New London, CT